(Total Views: 638)
Posted On: 09/04/2020 2:16:32 PM
Post# of 153967
Quote:
Leronlimab's partial blockade was lucky happenstance when it came to other indications.
Read More: https://investorshangout.com/post/view?id=588...z6X6ABX1xs
Lucky, sure... that's also Leronlimab's "moat" and likely a factor in how adroitly it modulates the CCR5/CCL5 axis, possibly safety profile, too. Some MABs Have All the Luck.
(0)
(0)
